Back to search
Infarction, Middle Cerebral Artery
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Infarction, Middle Cerebral Artery trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Infarction, Middle Cerebral Artery trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
In adult patients presenting to emergency departments within 24 hours of symptom onset with suspected acute stroke, we aim: 1. to identify early brain- and pat…
The main purpose of the current studies is to evaluate the safety and tolerability of psilocybin in patients with chronic stroke.
The CMOSS-2 trial is a government-funded, prospective, multicenter, randomized controlled trial. It will recruit symptomatic chronic occlusion of the middle cer…
A multicenter, prospective, open-label, blinded-endpoint, randomized controlled trial to assess the effectiveness and safety of catheter-based focal intracrania…
Middle cerebral artery (MCA) stroke often causes weakness or stiffness in the arm and hand, making daily activities difficult. This study compares two physical…
The purpose of this study is to investigate the safety and efficacy of endovascular treatment with or without preceding intravenous Tenecteplase in patients wit…